argenx SE | Investor Presentation Deck | 26 slides · page 23 of 26
Clinical trial design schematic showing 2:1 randomization between Efgartigimod and Placebo over 24 weeks.
Conference presentation · other · present_framework · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 diagram 1/1 list 2/2 title 1/1
Components 5
primary process bullet bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1